nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case report of combined treatment of gilteritinib and LH-RH agonist for Fms-related tyrosine kinase 3 receptor mutation-positive acute myeloid leukemia and bone marrow metastasis of prostate cancer
|
Onaka, Takashi |
|
|
101 |
2 |
p. 457-458 |
artikel |
2 |
Acute stroke in young adult secondary to moyamoya angiopathy unveiling HbE-β thalassemia
|
Das, Shambaditya |
|
|
101 |
2 |
p. 449-451 |
artikel |
3 |
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study
|
Pasvolsky, Oren |
|
|
101 |
2 |
p. 379-387 |
artikel |
4 |
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital
|
Garcia Borrega, Jorge |
|
|
101 |
2 |
p. 389-395 |
artikel |
5 |
Assay sensitivity of flow cytometric PNH analysis: response to Brando and Gatti
|
Hosokawa, Kohei |
|
|
101 |
2 |
p. 461-464 |
artikel |
6 |
Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
|
Paunescu, Alexandra‑Cristina |
|
|
101 |
2 |
p. 333 |
artikel |
7 |
Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
|
Tabata, Rikako |
|
|
101 |
2 |
p. 465-467 |
artikel |
8 |
ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy
|
Keren-Froim, Naama |
|
|
101 |
2 |
p. 309-316 |
artikel |
9 |
Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience
|
Yan, Fei |
|
|
101 |
2 |
p. 397-408 |
artikel |
10 |
Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?
|
Martins, Suellen Rodrigues |
|
|
101 |
2 |
p. 273-280 |
artikel |
11 |
Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus
|
Kishi, Tomohiro |
|
|
101 |
2 |
p. 453-455 |
artikel |
12 |
Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts
|
El Fakih, Riad |
|
|
101 |
2 |
p. 421-428 |
artikel |
13 |
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
|
Di Giacomo, Danika |
|
|
101 |
2 |
p. 297-307 |
artikel |
14 |
Ixazomib as treatment for pyoderma gangrenosum associated with IgA smoldering multiple myeloma
|
Cespedes, David Alvarez |
|
|
101 |
2 |
p. 441-442 |
artikel |
15 |
Langerhans cell histiocytosis in adults: a retrospective, single-center case series
|
Chiaravalli, Stefano |
|
|
101 |
2 |
p. 265-272 |
artikel |
16 |
Non-Hodgkin lymphomas and ionizing radiation: case report and review of the literature
|
Schmitz-Feuerhake, Inge |
|
|
101 |
2 |
p. 243-250 |
artikel |
17 |
Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapy
|
Hu, Xiao |
|
|
101 |
2 |
p. 369-378 |
artikel |
18 |
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
|
Krishnan, Mridula |
|
|
101 |
2 |
p. 335-340 |
artikel |
19 |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen |
|
|
101 |
2 |
p. 349-358 |
artikel |
20 |
Pregnancy outcome in women with transfused beta-thalassemia in France
|
Virot, Emilie |
|
|
101 |
2 |
p. 289-296 |
artikel |
21 |
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
|
Paunescu, Alexandra-Cristina |
|
|
101 |
2 |
p. 317-332 |
artikel |
22 |
Rare presentation of myeloma with diffuse osteosclerotic lesions without features of POEMS
|
Zheng, Winston |
|
|
101 |
2 |
p. 429-430 |
artikel |
23 |
Re: Hosokawa K et al. Assay sensitivity of flow cytometric PNH analysis
|
Brando, Bruno |
|
|
101 |
2 |
p. 459-460 |
artikel |
24 |
Re: Risk factors and predictors of treatment responses and complications in immune thrombocytopenia
|
Mishra, Kundan |
|
|
101 |
2 |
p. 447-448 |
artikel |
25 |
Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants
|
Yi, Eun Sang |
|
|
101 |
2 |
p. 409-419 |
artikel |
26 |
Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids
|
Hsieh, Tien-Chan |
|
|
101 |
2 |
p. 431-432 |
artikel |
27 |
Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients
|
Stanganelli, Carmen |
|
|
101 |
2 |
p. 341-348 |
artikel |
28 |
Successful treatment by using a modified SMILE regimen and autologous hematopoietic stem cell transplantation in a pediatric primary EBV-positive nodular NK/T cell lymphoma patient
|
Li, Jian |
|
|
101 |
2 |
p. 433-435 |
artikel |
29 |
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey
|
Dingli, David |
|
|
101 |
2 |
p. 251-263 |
artikel |
30 |
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
|
Dunn, William G. |
|
|
101 |
2 |
p. 443-445 |
artikel |
31 |
The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia
|
Pereira-Martins, Diego A. |
|
|
101 |
2 |
p. 281-287 |
artikel |
32 |
The role of KIAA1191 in the necroptotic pathway of multiple myeloma
|
Xu, Zhao |
|
|
101 |
2 |
p. 359-367 |
artikel |
33 |
Treatment burden in multiple myeloma according to comorbidity in real life
|
Pérez Persona, Ernesto |
|
|
101 |
2 |
p. 437-440 |
artikel |